世界のB型肝炎治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hepatitis B Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5776 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、B型肝炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・B型肝炎治療薬の市場動向 ・企業の競争状況、市場シェア ・B型肝炎治療薬の種類別市場規模と予測2016-2027（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他） ・B型肝炎治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局＆ドラッグストア、その他） ・B型肝炎治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・B型肝炎治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・B型肝炎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・B型肝炎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・B型肝炎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Bristol-Myers Squibb、Mitsubishi Tanabe Pharma、Johnson & Johnson、Roche、Gilead Sciences、Merck & Co. Inc.、Novartis、AbbVie） ・結論

Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (Viread), lamivudine (Epivir), adefovir (Hepsera) and telbivudine (Tyzeka) — can help fight the virus and slow its ability to damage your liver.

Market Analysis and Insights: Global Hepatitis B Drug Market
The global Hepatitis B Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis B Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis B Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis B Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis B Drug market.

Global Hepatitis B Drug Scope and Market Size
Hepatitis B Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis B Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Entecavir
Tenofovir
Lamivudine
Adefovir
Telbivudine
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Bristol-Myers Squibb
Mitsubishi Tanabe Pharma
Johnson & Johnson
Roche
Gilead Sciences
Merck & Co. Inc.
Novartis
AbbVie

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis B Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Entecavir
1.2.3 Tenofovir
1.2.4 Lamivudine
1.2.5 Adefovir
1.2.6 Telbivudine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Hepatitis B Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies & Drug Stores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hepatitis B Drug Market Perspective (2016-2027)
2.2 Hepatitis B Drug Growth Trends by Regions
2.2.1 Hepatitis B Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hepatitis B Drug Historic Market Share by Regions (2016-2021)
2.2.3 Hepatitis B Drug Forecasted Market Size by Regions (2022-2027)
2.3 Hepatitis B Drug Industry Dynamic
2.3.1 Hepatitis B Drug Market Trends
2.3.2 Hepatitis B Drug Market Drivers
2.3.3 Hepatitis B Drug Market Challenges
2.3.4 Hepatitis B Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hepatitis B Drug Players by Revenue
3.1.1 Global Top Hepatitis B Drug Players by Revenue (2016-2021)
3.1.2 Global Hepatitis B Drug Revenue Market Share by Players (2016-2021)
3.2 Global Hepatitis B Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatitis B Drug Revenue
3.4 Global Hepatitis B Drug Market Concentration Ratio
3.4.1 Global Hepatitis B Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B Drug Revenue in 2020
3.5 Hepatitis B Drug Key Players Head office and Area Served
3.6 Key Players Hepatitis B Drug Product Solution and Service
3.7 Date of Enter into Hepatitis B Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hepatitis B Drug Breakdown Data by Type
4.1 Global Hepatitis B Drug Historic Market Size by Type (2016-2021)
4.2 Global Hepatitis B Drug Forecasted Market Size by Type (2022-2027)

5 Hepatitis B Drug Breakdown Data by Application
5.1 Global Hepatitis B Drug Historic Market Size by Application (2016-2021)
5.2 Global Hepatitis B Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hepatitis B Drug Market Size (2016-2027)
6.2 North America Hepatitis B Drug Market Size by Type
6.2.1 North America Hepatitis B Drug Market Size by Type (2016-2021)
6.2.2 North America Hepatitis B Drug Market Size by Type (2022-2027)
6.2.3 North America Hepatitis B Drug Market Size by Type (2016-2027)
6.3 North America Hepatitis B Drug Market Size by Application
6.3.1 North America Hepatitis B Drug Market Size by Application (2016-2021)
6.3.2 North America Hepatitis B Drug Market Size by Application (2022-2027)
6.3.3 North America Hepatitis B Drug Market Size by Application (2016-2027)
6.4 North America Hepatitis B Drug Market Size by Country
6.4.1 North America Hepatitis B Drug Market Size by Country (2016-2021)
6.4.2 North America Hepatitis B Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hepatitis B Drug Market Size (2016-2027)
7.2 Europe Hepatitis B Drug Market Size by Type
7.2.1 Europe Hepatitis B Drug Market Size by Type (2016-2021)
7.2.2 Europe Hepatitis B Drug Market Size by Type (2022-2027)
7.2.3 Europe Hepatitis B Drug Market Size by Type (2016-2027)
7.3 Europe Hepatitis B Drug Market Size by Application
7.3.1 Europe Hepatitis B Drug Market Size by Application (2016-2021)
7.3.2 Europe Hepatitis B Drug Market Size by Application (2022-2027)
7.3.3 Europe Hepatitis B Drug Market Size by Application (2016-2027)
7.4 Europe Hepatitis B Drug Market Size by Country
7.4.1 Europe Hepatitis B Drug Market Size by Country (2016-2021)
7.4.2 Europe Hepatitis B Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hepatitis B Drug Market Size (2016-2027)
8.2 Asia-Pacific Hepatitis B Drug Market Size by Type
8.2.1 Asia-Pacific Hepatitis B Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hepatitis B Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hepatitis B Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Hepatitis B Drug Market Size by Application
8.3.1 Asia-Pacific Hepatitis B Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hepatitis B Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hepatitis B Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Hepatitis B Drug Market Size by Region
8.4.1 Asia-Pacific Hepatitis B Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hepatitis B Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hepatitis B Drug Market Size (2016-2027)
9.2 Latin America Hepatitis B Drug Market Size by Type
9.2.1 Latin America Hepatitis B Drug Market Size by Type (2016-2021)
9.2.2 Latin America Hepatitis B Drug Market Size by Type (2022-2027)
9.2.3 Latin America Hepatitis B Drug Market Size by Type (2016-2027)
9.3 Latin America Hepatitis B Drug Market Size by Application
9.3.1 Latin America Hepatitis B Drug Market Size by Application (2016-2021)
9.3.2 Latin America Hepatitis B Drug Market Size by Application (2022-2027)
9.3.3 Latin America Hepatitis B Drug Market Size by Application (2016-2027)
9.4 Latin America Hepatitis B Drug Market Size by Country
9.4.1 Latin America Hepatitis B Drug Market Size by Country (2016-2021)
9.4.2 Latin America Hepatitis B Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hepatitis B Drug Market Size (2016-2027)
10.2 Middle East & Africa Hepatitis B Drug Market Size by Type
10.2.1 Middle East & Africa Hepatitis B Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hepatitis B Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hepatitis B Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Hepatitis B Drug Market Size by Application
10.3.1 Middle East & Africa Hepatitis B Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hepatitis B Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hepatitis B Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Hepatitis B Drug Market Size by Country
10.4.1 Middle East & Africa Hepatitis B Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hepatitis B Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Hepatitis B Drug Introduction
11.1.4 GlaxoSmithKline Revenue in Hepatitis B Drug Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Hepatitis B Drug Introduction
11.2.4 Bristol-Myers Squibb Revenue in Hepatitis B Drug Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Mitsubishi Tanabe Pharma
11.3.1 Mitsubishi Tanabe Pharma Company Details
11.3.2 Mitsubishi Tanabe Pharma Business Overview
11.3.3 Mitsubishi Tanabe Pharma Hepatitis B Drug Introduction
11.3.4 Mitsubishi Tanabe Pharma Revenue in Hepatitis B Drug Business (2016-2021)
11.3.5 Mitsubishi Tanabe Pharma Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Hepatitis B Drug Introduction
11.4.4 Johnson & Johnson Revenue in Hepatitis B Drug Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Hepatitis B Drug Introduction
11.5.4 Roche Revenue in Hepatitis B Drug Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Gilead Sciences
11.6.1 Gilead Sciences Company Details
11.6.2 Gilead Sciences Business Overview
11.6.3 Gilead Sciences Hepatitis B Drug Introduction
11.6.4 Gilead Sciences Revenue in Hepatitis B Drug Business (2016-2021)
11.6.5 Gilead Sciences Recent Development
11.7 Merck & Co. Inc.
11.7.1 Merck & Co. Inc. Company Details
11.7.2 Merck & Co. Inc. Business Overview
11.7.3 Merck & Co. Inc. Hepatitis B Drug Introduction
11.7.4 Merck & Co. Inc. Revenue in Hepatitis B Drug Business (2016-2021)
11.7.5 Merck & Co. Inc. Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Hepatitis B Drug Introduction
11.8.4 Novartis Revenue in Hepatitis B Drug Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Hepatitis B Drug Introduction
11.9.4 AbbVie Revenue in Hepatitis B Drug Business (2016-2021)
11.9.5 AbbVie Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hepatitis B Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Entecavir
Table 3. Key Players of Tenofovir
Table 4. Key Players of Lamivudine
Table 5. Key Players of Adefovir
Table 6. Key Players of Telbivudine
Table 7. Key Players of Others
Table 8. Global Hepatitis B Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hepatitis B Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Hepatitis B Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Hepatitis B Drug Market Share by Regions (2016-2021)
Table 12. Global Hepatitis B Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Hepatitis B Drug Market Share by Regions (2022-2027)
Table 14. Hepatitis B Drug Market Trends
Table 15. Hepatitis B Drug Market Drivers
Table 16. Hepatitis B Drug Market Challenges
Table 17. Hepatitis B Drug Market Restraints
Table 18. Global Hepatitis B Drug Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Hepatitis B Drug Market Share by Players (2016-2021)
Table 20. Global Top Hepatitis B Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Drug as of 2020)
Table 21. Ranking of Global Top Hepatitis B Drug Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Hepatitis B Drug Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hepatitis B Drug Product Solution and Service
Table 25. Date of Enter into Hepatitis B Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hepatitis B Drug Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Hepatitis B Drug Revenue Market Share by Type (2016-2021)
Table 29. Global Hepatitis B Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Hepatitis B Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Hepatitis B Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Hepatitis B Drug Revenue Market Share by Application (2016-2021)
Table 33. Global Hepatitis B Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Hepatitis B Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Hepatitis B Drug Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Hepatitis B Drug Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Hepatitis B Drug Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Hepatitis B Drug Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Hepatitis B Drug Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Hepatitis B Drug Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Hepatitis B Drug Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Hepatitis B Drug Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Hepatitis B Drug Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Hepatitis B Drug Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Hepatitis B Drug Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Hepatitis B Drug Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hepatitis B Drug Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Hepatitis B Drug Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Hepatitis B Drug Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Hepatitis B Drug Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Hepatitis B Drug Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Hepatitis B Drug Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Hepatitis B Drug Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Hepatitis B Drug Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Hepatitis B Drug Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Hepatitis B Drug Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Hepatitis B Drug Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Hepatitis B Drug Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hepatitis B Drug Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Hepatitis B Drug Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Hepatitis B Drug Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Hepatitis B Drug Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Hepatitis B Drug Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Hepatitis B Drug Market Size by Country (2022-2027) & (US$ Million)
Table 65. GlaxoSmithKline Company Details
Table 66. GlaxoSmithKline Business Overview
Table 67. GlaxoSmithKline Hepatitis B Drug Product
Table 68. GlaxoSmithKline Revenue in Hepatitis B Drug Business (2016-2021) & (US$ Million)
Table 69. GlaxoSmithKline Recent Development
Table 70. Bristol-Myers Squibb Company Details
Table 71. Bristol-Myers Squibb Business Overview
Table 72. Bristol-Myers Squibb Hepatitis B Drug Product
Table 73. Bristol-Myers Squibb Revenue in Hepatitis B Drug Business (2016-2021) & (US$ Million)
Table 74. Bristol-Myers Squibb Recent Development
Table 75. Mitsubishi Tanabe Pharma Company Details
Table 76. Mitsubishi Tanabe Pharma Business Overview
Table 77. Mitsubishi Tanabe Pharma Hepatitis B Drug Product
Table 78. Mitsubishi Tanabe Pharma Revenue in Hepatitis B Drug Business (2016-2021) & (US$ Million)
Table 79. Mitsubishi Tanabe Pharma Recent Development
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Hepatitis B Drug Product
Table 83. Johnson & Johnson Revenue in Hepatitis B Drug Business (2016-2021) & (US$ Million)
Table 84. Johnson & Johnson Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Hepatitis B Drug Product
Table 88. Roche Revenue in Hepatitis B Drug Business (2016-2021) & (US$ Million)
Table 89. Roche Recent Development
Table 90. Gilead Sciences Company Details
Table 91. Gilead Sciences Business Overview
Table 92. Gilead Sciences Hepatitis B Drug Product
Table 93. Gilead Sciences Revenue in Hepatitis B Drug Business (2016-2021) & (US$ Million)
Table 94. Gilead Sciences Recent Development
Table 95. Merck & Co. Inc. Company Details
Table 96. Merck & Co. Inc. Business Overview
Table 97. Merck & Co. Inc. Hepatitis B Drug Product
Table 98. Merck & Co. Inc. Revenue in Hepatitis B Drug Business (2016-2021) & (US$ Million)
Table 99. Merck & Co. Inc. Recent Development
Table 100. Novartis Company Details
Table 101. Novartis Business Overview
Table 102. Novartis Revenue in Hepatitis B Drug Business (2016-2021) & (US$ Million)
Table 103. Novartis Recent Development
Table 104. AbbVie Company Details
Table 105. AbbVie Business Overview
Table 106. AbbVie Hepatitis B Drug Product
Table 107. AbbVie Revenue in Hepatitis B Drug Business (2016-2021) & (US$ Million)
Table 108. AbbVie Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis B Drug Market Share by Type: 2020 VS 2027
Figure 2. Entecavir Features
Figure 3. Tenofovir Features
Figure 4. Lamivudine Features
Figure 5. Adefovir Features
Figure 6. Telbivudine Features
Figure 7. Others Features
Figure 8. Global Hepatitis B Drug Market Share by Application: 2020 VS 2027
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies & Drug Stores Case Studies
Figure 11. Others Case Studies
Figure 12. Hepatitis B Drug Report Years Considered
Figure 13. Global Hepatitis B Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Hepatitis B Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Hepatitis B Drug Market Share by Regions: 2020 VS 2027
Figure 16. Global Hepatitis B Drug Market Share by Regions (2022-2027)
Figure 17. Global Hepatitis B Drug Market Share by Players in 2020
Figure 18. Global Top Hepatitis B Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Drug as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Hepatitis B Drug Revenue in 2020
Figure 20. Global Hepatitis B Drug Revenue Market Share by Type (2016-2021)
Figure 21. Global Hepatitis B Drug Revenue Market Share by Type (2022-2027)
Figure 22. North America Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Hepatitis B Drug Market Share by Type (2016-2027)
Figure 24. North America Hepatitis B Drug Market Share by Application (2016-2027)
Figure 25. North America Hepatitis B Drug Market Share by Country (2016-2027)
Figure 26. United States Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Hepatitis B Drug Market Share by Type (2016-2027)
Figure 30. Europe Hepatitis B Drug Market Share by Application (2016-2027)
Figure 31. Europe Hepatitis B Drug Market Share by Country (2016-2027)
Figure 32. Germany Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Hepatitis B Drug Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Hepatitis B Drug Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Hepatitis B Drug Market Share by Region (2016-2027)
Figure 42. China Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Hepatitis B Drug Market Share by Type (2016-2027)
Figure 50. Latin America Hepatitis B Drug Market Share by Application (2016-2027)
Figure 51. Latin America Hepatitis B Drug Market Share by Country (2016-2027)
Figure 52. Mexico Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Hepatitis B Drug Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Hepatitis B Drug Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Hepatitis B Drug Market Share by Country (2016-2027)
Figure 58. Turkey Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Hepatitis B Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Hepatitis B Drug Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis B Drug Business (2016-2021)
Figure 63. Mitsubishi Tanabe Pharma Revenue Growth Rate in Hepatitis B Drug Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Hepatitis B Drug Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Hepatitis B Drug Business (2016-2021)
Figure 66. Gilead Sciences Revenue Growth Rate in Hepatitis B Drug Business (2016-2021)
Figure 67. Merck & Co. Inc. Revenue Growth Rate in Hepatitis B Drug Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Hepatitis B Drug Business (2016-2021)
Figure 69. AbbVie Revenue Growth Rate in Hepatitis B Drug Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---